1. Home
  2. PAHC vs ENOV Comparison

PAHC vs ENOV Comparison

Compare PAHC & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$40.78

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$27.24

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAHC
ENOV
Founded
1946
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
PAHC
ENOV
Price
$40.78
$27.24
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$31.25
$49.14
AVG Volume (30 Days)
273.3K
854.1K
Earning Date
02-04-2026
11-06-2025
Dividend Yield
1.18%
N/A
EPS Growth
288.74
N/A
EPS
1.67
N/A
Revenue
$1,399,676,000.00
$2,233,266,000.00
Revenue This Year
$15.34
$9.27
Revenue Next Year
$3.28
$4.56
P/E Ratio
$24.30
N/A
Revenue Growth
33.72
11.57
52 Week Low
$16.16
$25.47
52 Week High
$46.42
$49.38

Technical Indicators

Market Signals
Indicator
PAHC
ENOV
Relative Strength Index (RSI) 48.75 43.46
Support Level $39.39 $25.52
Resistance Level $41.62 $28.02
Average True Range (ATR) 1.66 1.28
MACD -0.02 -0.03
Stochastic Oscillator 63.50 31.79

Price Performance

Historical Comparison
PAHC
ENOV

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: